CTOR vs GEN · $105.2M cap vs P/E 17, rev $5.00B
Citius Oncology, Inc. (CTOR) versus Gen Digital Inc. (GEN) — a side-by-side from cached financials, not a winner call.
Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
Gen Digital Inc. (GEN) is a software - infrastructure company listed on US.
CTOR does not have a complete income-statement cache yet.
Latest reported GEN revenue for 2026-04-03 was $5.00B. Net income was $973.0M. Revenue was up 27.1% from 2025-03-28 to 2026-04-03. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
CTOR currently screens at market cap $105.2M. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
Not investment advice. Open the CTOR and GEN stock pages for the full models.
Not investment advice.